BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 6091394)

  • 1. SMON as seen from Bombay.
    Wadia NH
    Acta Neurol Scand Suppl; 1984; 100():159-64. PubMed ID: 6091394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A neurological evaluation of purported cases of SMON in Sweden.
    Gilland O
    Acta Neurol Scand Suppl; 1984; 100():165-9. PubMed ID: 6091395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurotoxicity of halogenated hydroxyquinolines: non-Japanese cases.
    Thomas PK
    Acta Neurol Scand Suppl; 1984; 100():155-8. PubMed ID: 6091393
    [No Abstract]   [Full Text] [Related]  

  • 4. Some thoughts on 'SMON'.
    Pallis C
    Acta Neurol Scand Suppl; 1984; 100():147-53. PubMed ID: 6237544
    [No Abstract]   [Full Text] [Related]  

  • 5. Some observations on SMON from Bombay.
    Wadia NH
    J Neurol Neurosurg Psychiatry; 1977 Mar; 40(3):268-75. PubMed ID: 142126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clioquinol neurotoxicity: an overview.
    Clifford Rose F; Gawel M
    Acta Neurol Scand Suppl; 1984; 100():137-45. PubMed ID: 6237543
    [No Abstract]   [Full Text] [Related]  

  • 7. [A case of myelo-optic neuropathy preceded by abdominal symptoms].
    Massons Cirera J; Zunzunegui Costas J; Titus Alvareda F
    Med Clin (Barc); 1983 Jun; 80(20):894-5. PubMed ID: 6224988
    [No Abstract]   [Full Text] [Related]  

  • 8. Subacute myelo-optic neuropathy (SMON). First neuro-pathological report outside Japan.
    Ricoy JR; Ortega A; Cabello A
    J Neurol Sci; 1982 Feb; 53(2):241-51. PubMed ID: 6460092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [SMON: toxicity of clioquinol and the status quo].
    Konagaya M
    Brain Nerve; 2015 Jan; 67(1):49-62. PubMed ID: 25585435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subacute myelo-optico-neuropathy (SMON) in Japan. With special reference to the autopsy cases.
    Egashira Y; Matsuyama H
    Acta Pathol Jpn; 1982; 32 Suppl 1():101-16. PubMed ID: 6316716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurotoxicity of halogenated hydroxyquinolines: clinical analysis of cases reported outside Japan.
    Baumgartner G; Gawel MJ; Kaeser HE; Pallis CA; Rose FC; Schaumburg HH; Thomas PK; Wadia NH
    J Neurol Neurosurg Psychiatry; 1979 Dec; 42(12):1073-83. PubMed ID: 230316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical analysis of longstanding subacute myelo-optico-neuropathy: sequelae of clioquinol at 32 years after its ban.
    Konagaya M; Matsumoto A; Takase S; Mizutani T; Sobue G; Konishi T; Hayabara T; Iwashita H; Ujihira T; Miyata K; Matsuoka Y
    J Neurol Sci; 2004 Mar; 218(1-2):85-90. PubMed ID: 14759638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depression in patients with subacute myelo-optico-neuropathy (SMON).
    Konishi T; Hayashi K; Hayashi M; Ueno S; Yoshida S; Fujimura H; Funakawa I; Kaido M
    Intern Med; 2008; 47(24):2127-31. PubMed ID: 19075537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subacute myelo-optico-neuropathy: clioquinol intoxication in humans and animals.
    Tateishi J
    Neuropathology; 2000 Sep; 20 Suppl():S20-4. PubMed ID: 11037182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subacute myelo-optico-neuropathy (SMON)--neurotoxicity of clioquinols.
    Selby G
    Proc Aust Assoc Neurol; 1973; 9():23-30. PubMed ID: 4268933
    [No Abstract]   [Full Text] [Related]  

  • 16. Cervical MRI of subacute myelo-optico-neuropathy.
    Kimura E; Hirano T; Yamashita S; Hirai T; Uchida Y; Maeda Y; Uchino M
    Spinal Cord; 2011 Feb; 49(2):182-5. PubMed ID: 20548321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [SMON--a model of the iatrogenic disease].
    Takasu T
    Rinsho Shinkeigaku; 2003 Nov; 43(11):866-9. PubMed ID: 15152488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The aetiology of SMON may involve an interaction between clioquinol and environmental metals.
    Tjälve H
    Med Hypotheses; 1984 Nov; 15(3):293-9. PubMed ID: 6240588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The prevalence of dementia in subacute myelo-optico-neuropathy (SMON) patients who underwent medical checkups].
    Saito Y; Sakai K; Konagaya M
    Nihon Ronen Igakkai Zasshi; 2016; 53(2):152-7. PubMed ID: 27250222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sleep problems in subacute myelo-optico neuropathy (SMON).
    Hishikawa N; Takemoto M; Sato K; Yamashita T; Ohta Y; Sakai K; Abe K
    J Clin Neurosci; 2019 Oct; 68():128-133. PubMed ID: 31326286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.